查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1924659

内视镜黏膜下剥离刀市场按产品类型、模式、材质、最终用户和应用划分－2026-2032年全球预测

Endoscopic Submucosal Dissection Knives Market by Product Type, Mode, Material, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年内视镜黏膜下剥离刀市场价值为 1.5281 亿美元，预计到 2026 年将成长至 1.7586 亿美元，预计到 2032 年将达到 3.6747 亿美元，复合年增长率为 13.35%。

关键市场统计数据
基准年 2025 1.5281亿美元
预计年份：2026年 1.7586亿美元
预测年份 2032 3.6747亿美元
复合年增长率 (%) 13.35%

本文简要介绍了刀具设计、手术操作要求、临床医生需求以及监管预期如何影响先进内视镜解剖工具的应用。

内视镜黏膜下剥离刀是现代胃肠治疗性内视镜的核心工具，能够以精确可控的方式整块切除黏膜和黏膜下病变。本文将这些器械的临床应用置于更广泛的手术流程中，并阐明刀具的设计、材料选择和使用方式如何影响手术时间、病灶可及性和操作者的舒适度。从技术角度来看，刀具已从简单的切割刀片发展成为集绝缘、可变刀尖几何形状和与电外科能量兼容一体的复杂器械，以控制切割效率和热效应。

分析2025年美国关税措施对精密内视镜仪器的采购、製造决策及购买趋势的影响。

2025年的关税环境对跨境采购内视镜黏膜下剥离刀或其组件的製造商、经销商和采购部门而言，是一个关键的转捩点。关税提高了进口商品的到岸成本，促使他们重新评估供应商网路、库存缓衝和製造地。为此，一些原始设备製造商（OEM）加快了近岸外包和双重采购策略，以降低关税风险和运输波动的影响。同时，其他製造商则寻求设计变更，以在不影响临床性能的前提下替代课税组件。这些调整产生了连锁反应：采购团队必须权衡短期价格波动与供应商长期永续性之间的关係，而随着製造商优先考虑本地生产，临床医生可能面临设备配置的频繁变化。

深度細項分析将产品形态、使用方式、最终用户环境、临床应用和材料选择与采纳和采购决策联繫起来。

细分市场的发展趋势凸显了临床需求、筹资策略和产品设计之间的交集，为製造商和采购机构创造了差异化机会。产品类型的差异——从离合器切割器的扭矩控製到钩刀的精准定位，再到双刀的各种切割轮廓以及注重安全性的绝缘刀尖——每一种都针对特定的病变特征和操作技术，指南临床实践中的器械选择。同样，一次性使用与可重复使用两种交付方式也决定了物流、消毒基础设施和感染控制通讯协定的权衡。一次性使用方式会增加周转率，而可重复使用的器械则需要检验的消毒和维护程序。

区域比较分析突显了监管细微差别、临床医生培训环境和製造地分布如何导致全球市场采用率的差异

区域趋势正在形成差异化的市场，法规结构、临床医生培训和製造地等因素共同影响医疗器材的供应和应用。在美洲，治疗性内视镜领域成熟的临床经验、大型医院系统的集中采购以及对提升手术安全性和效率的创新技术的需求，共同影响市场需求。该地区供应链的反应速度和与製造地的接近性也会影响前置作业时间和供应商选择策略，从而支持国内生产和特定零件的定向进口。

治疗性内视镜领域的差异化因素：以临床证据、供应链韧性与整合服务模式为驱动的公司层面竞争考察

内视镜黏膜下剥离刀供应商之间的竞争主要围绕在几个核心主题：透过临床证据实现差异化、操作可靠性和综合支援服务。主要企业致力于迭代式产品研发，旨在改进刀尖几何形状和绝缘性能，同时建立临床伙伴关係，以进行同行评审的研究并制定操作指南。追求一次性产品的企业则专注于供应链物流、包装和一次性使用品质保证。同时，专注于可重复使用平台的企业则投资于耐用材料和检验的灭菌通讯协定，以延长产品使用寿命并降低整体拥有成本。

针对製造商、临床领导者和采购团队的实用建议：协调产品策略、供应链韧性和临床实施活动

产业领导者应采取协作策略，平衡当前的营运需求与持续的创新投资。首先，应优先考虑供应链多元化和近岸外包方案，以降低关税带来的成本和前置作业时间波动风险，同时筛选替代材料来源并维持设备性能。其次，应设计满足不同终端使用者偏好并涵盖所有产品系列的产品组合，提供诸如离合器切割器和钩刀等互补型产品，并提供一次性使用和可重复使用两种型号。第三，需要投资临床证据的收集和系统的训练项目。令人信服的疗效数据，结合实践指导，可以加速医院和专科诊所的推广应用，并促进相关技术纳入临床指南。

研究采用透明的调查方法，结合临床医生访谈、监管和专利分析、供应链映射和情境测试来检验研究结果。

本报告的研究整合了第一手和第二手资料，旨在对内视镜黏膜下剥离刀的现状形成全面、可操作的分析。第一手资料包括介入内视镜医师、采购经理、消毒技师和临床负责人的结构化访谈，以及来自手术室和训练中心的观察性研究结果。这些定性数据与监管文件、医疗设备使用手册、临床试验报告以及同行评审文献进行了交叉比对，以检验性能声明和安全性数据。专利研究和材料分析则提供了有关技术差异化和竞争性创新管道的见解。

最后，我们提出一项综合分析，重点在于阐述设备创新、供应链韧性、临床证据和区域采用趋势之间的相互作用，以指南策略行动。

总之，内视镜黏膜下剥离刀正经历一场变革，其驱动力来自器械几何结构、材料科学和操作训练的同步进步。同时，宏观经济和政策因素，例如关税，正在重塑供应链策略。随着越来越多的中心采用先进的切除技术，临床需求不断增长，但成功的商业化取决于如何使器械特性适应不同终端使用者、临床应用和区域法规环境的细微需求。材料和规格的选择——陶瓷与先进钢材、一次性使用与可重复使用——仍然是影响灭菌流程、临床医生偏好和采购成本的关键决策。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 内视镜黏膜下剥离刀市场（依产品类型划分）

  • 离合器切割器
  • 双刃刀
  • 钩刀
  • 绝缘刀尖

9. 内视镜黏膜下剥离刀市场（依模式划分）

  • 一次性
  • 可重复使用的

第十章 内视镜黏膜下剥离刀市场（依材料分类）

  • 陶瓷製品
  • 高碳钢
  • 不銹钢

第十一章 内视镜黏膜下剥离刀市场（依最终用户划分）

  • 门诊手术中心
  • 医院
  • 专科诊所

第十二章 内视镜黏膜下剥离刀市场（依应用领域划分）

  • 结肠病变
  • 十二指肠病变
  • 食道病变
  • 胃部病变

13. 内视镜黏膜下剥离刀市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 内视镜黏膜下剥离刀市场（按组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国内镜粘膜下剥离刀市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国内视镜黏膜下剥离刀市场

第十七章 中国内镜黏膜下剥离刀市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical LLC
  • Creo Medical
  • ENDO-FLEX GmbH
  • Erbe Elektromedizin GmbH
  • Finemedix
  • FUJIFILM Holdings Corporation
  • Hangzhou AGS
  • Hoya Corporation
  • Kachu
  • KARL STORZ SE & Co. KG
  • Medi-Globe GmbH
  • Medtronic plc
  • Micro-Tech Endoscopy Co., Ltd.
  • MTW Endoskopie Manufaktur
  • Olympus Corporation
  • Ovesco Endoscopy AG
  • STERIS plc
  • Sumitomo Bakelite Co., Ltd.
  • Taewoong Medical Co., Ltd.
  • ZEON CORPORATION
  • Zhejiang Soudon Medical Technology Co., Ltd.
Product Code: MRR-7A380DA7C405

The Endoscopic Submucosal Dissection Knives Market was valued at USD 152.81 million in 2025 and is projected to grow to USD 175.86 million in 2026, with a CAGR of 13.35%, reaching USD 367.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 152.81 million
Estimated Year [2026] USD 175.86 million
Forecast Year [2032] USD 367.47 million
CAGR (%) 13.35%

Concise introduction explaining how knife design, procedural demands, clinician needs, and regulatory expectations shape adoption of advanced endoscopic dissection tools

Endoscopic submucosal dissection knives are central to modern gastrointestinal therapeutic endoscopy, enabling en bloc resection of mucosal and submucosal lesions with precision and controlled hemostasis. This introduction frames the clinical purpose of these instruments within the broader procedural pathway, clarifying how knife design, material selection, and mode of use influence procedural time, ease of lesion access, and operator ergonomics. From a technology perspective, knives have evolved from simple cutting edges to complex instruments that integrate insulation, variable tip geometry, and compatibility with electrosurgical energy to manage cutting efficiency and thermal effects.

Adoption dynamics are shaped by a set of interlinked stakeholders: interventional endoscopists demanding high tactile feedback and safety margins, procurement teams balancing single-use infection control concerns with cost-efficiency, and device engineers iterating on materials such as ceramic and advanced steels to optimize durability and cut performance. Regulatory pathways and clinical evidence requirements are becoming more structured, with an emphasis on procedural outcomes and adverse event reporting. Consequently, strategic decisions around product portfolio, training investment, and regional market entry must be grounded in an understanding of procedural workflows and clinician preferences. Throughout this report, the foundational role of knife design in enabling clinician confidence and patient safety is emphasized, with practical implications for commercialization and clinical adoption.

The landscape for endoscopic submucosal dissection knives is undergoing multiple transformative shifts that are redefining product development, procurement, and clinical practice. Technological refinement of tip geometry and insulation is improving precision while reducing collateral thermal injury, and the emergence of specialized designs-such as clutch-style cutters and hooked configurations-has expanded the range of resection techniques clinicians can apply. Parallel to these engineering advances, materials science has introduced alternatives like ceramic and high-carbon steel that deliver distinct trade-offs between edge retention, friction characteristics, and compatibility with energy delivery systems. These material choices now drive product segmentation decisions and influence clinician preference for specific lesion types.

At the same time, the debate between disposable and reusable modes is intensifying as infection control priorities converge with cost and environmental concerns. Disposable devices simplify logistics and reduce cross-contamination risk, whereas reusable instruments demand validated sterilization pathways and durable materials. Training and proctoring programs are also evolving; simulation-based curricula and mentorship networks are accelerating procedural proficiency, which in turn is broadening the set of clinical indications for which ESD is offered. Moreover, procedural settings are diversifying: ambulatory surgical centers, hospitals, and specialty clinics are calibrating their capital and staffing models to accommodate longer therapeutic endoscopy sessions. Finally, macro pressures-such as supply chain localization and tariff changes-are prompting manufacturers to reassess sourcing, inventory strategies, and pricing models, thereby influencing product availability and procurement economics worldwide.

Analysis of how the 2025 United States tariff measures reshaped sourcing, manufacturing decisions, and procurement dynamics for precision endoscopic tools

The tariff environment introduced in 2025 introduced a material inflection point for manufacturers, distributors, and purchasing departments that source endoscopic submucosal dissection knives or their components across borders. Tariffs raise the landed cost of imports and create incentives to re-evaluate supplier networks, inventory buffers, and manufacturing footprints. In response, some original equipment manufacturers accelerated nearshoring and dual-sourcing strategies to mitigate exposure to customs duties and shipping volatility, while others pursued engineering redesigns to substitute tariff-exposed components without compromising clinical performance. These adaptations have ripple effects: procurement teams must weigh short-term price variability against long-term supplier resilience, and clinicians may encounter periodic shifts in device mix as manufacturers prioritize local production.

Concurrently, tariffs interact with reimbursement realities and hospital procurement cycles. Purchasing groups can face tighter negotiation windows and may demand longer performance guarantees or bundled service contracts to offset perceived cost risk. The tariffs also influenced the relative economics of disposable versus reusable devices because import duties applied to consumables can compound per-procedure cost, prompting some centers to favor locally manufactured reusable options when sterilization capacity exists. Importantly, the tariff-driven reconfiguration of supply chains can affect lead times for specialized instruments, potentially altering clinical scheduling and inventory policies. Overall, the cumulative impact is a strategic push toward supply chain agility and a closer alignment between manufacturing location, material selection, and commercial positioning to sustain device availability and clinical continuity.

Deep segmentation insights linking product geometry, usage mode, end-user setting, clinical application, and material choice to adoption and procurement decisions

Segment-specific dynamics reveal where clinical need, procurement strategy, and product engineering intersect to create differentiation opportunities for manufacturers and buying organizations. Product type distinctions-ranging from the torque-control offered by clutch cutters to the targeted access of hook knives, the versatile cutting profiles of dual knives, and the safety-focused insulated tip knives-each map to particular lesion characteristics and operator techniques, informing device selection in real-world practice. Similarly, the mode of delivery, whether disposable or reusable, drives trade-offs in logistics, sterilization infrastructure, and infection control protocols; disposable formats streamline turnover while reusable instruments demand validated sterilization and maintenance pathways.

End-user segmentation matters because procedural volume, staffing models, and capital constraints vary across ambulatory surgical centers, hospitals, and specialty clinics. Ambulatory surgical centers, whether freestanding or hospital-based, prioritize throughput and predictable case scheduling; private and public hospitals differ in procurement governance and budget cycles; and specialty clinics focused on gastrointestinal care or outpatient endoscopy centers tailor investments to subspecialty demand. Clinical application segmentation further refines product fit: device attributes that support en bloc resection and hemostatic control are prioritized for esophageal and gastric lesions, while the handling and reach characteristics required for colonic or duodenal lesions influence the selection between different knife geometries and materials. Material choices-ceramic, high-carbon steel, and stainless steel-also translate into specific user value propositions, such as edge longevity, thermal behavior, and sterilization compatibility. Taken together, these segmentation lenses enable stakeholders to align product portfolios with clinical workflows and procurement realities for maximum impact.

Comparative regional insights showing how regulatory nuance, clinician training ecosystems, and manufacturing footprints drive differential adoption across global markets

Regional dynamics create differentiated markets where regulatory frameworks, clinician training ecosystems, and manufacturing footprints shape device availability and adoption rates. In the Americas, demand is influenced by a combination of established clinical expertise in therapeutic endoscopy, concentrated purchasing through large hospital systems, and an appetite for innovations that enhance procedural safety and throughput. The region's supply chain responsiveness and proximity to manufacturing hubs also affect lead times and supplier selection strategies, supporting both domestic production and targeted importation of specialized components.

Europe, the Middle East & Africa presents a heterogeneous environment where regulatory harmonization across jurisdictions interacts with variable reimbursement policies and diverse clinical capacities. In several markets, centralized procurement and tendering processes create pressure for demonstrable clinical value, whereas in others, private specialty clinics act as early adopters for novel knife designs. Training networks and centers of excellence play an outsized role in clinician adoption in this region, often dictating the pace at which advanced ESD techniques diffuse. Asia-Pacific is characterized by a combination of high procedural volumes in major urban centers, strong local manufacturing capabilities, and rapid clinical adoption driven by procedural expertise and national screening programs. Regional supply chain integration and domestic production capacities often mitigate tariff impacts, while local regulatory pathways and clinician training initiatives accelerate market entry for regionally produced innovations. Across all regions, alignment between clinical evidence, local regulatory expectations, and distribution capabilities is essential to successfully introduce new device variants.

Competitive company-level insights showing how clinical evidence, supply resilience, and integrated service models drive differentiation in therapeutic endoscopy devices

Competitive dynamics among firms supplying endoscopic submucosal dissection knives center on a few persistent themes: differentiation through clinical evidence, operational reliability, and integrated support services. Leading organizations invest in iterative product development that refines tip geometry and insulation, while also establishing clinical partnerships to generate peer-reviewed outcomes and procedural guidance. Companies pursuing disposable formats emphasize supply chain logistics, packaging, and single-use quality assurance, whereas those focusing on reusable platforms invest in durable materials and validated sterilization protocols to extend product lifecycle and reduce total cost of ownership.

Strategic alliances with distributors, hospital purchasing coalitions, and training institutions are common tactics to accelerate clinical adoption and expand installed bases. Additionally, service models that bundle device supply with consumable management, clinician training, and real-world evidence collection offer differentiated value propositions to large end users. Intellectual property around blade design and energy compatibility can create competitive moats, but the faster pace of incremental innovation means firms must balance R&D depth with rapid commercialization. Finally, firms that proactively address supply chain resilience by diversifying components, qualifying alternate manufacturing sites, and developing modular designs are better positioned to navigate tariff volatility and procurement cycles while maintaining clinical continuity for customers.

Actionable recommendations for manufacturers, clinical leaders, and procurement teams to align product strategy, supply resilience, and clinical adoption efforts

Industry leaders should pursue a coordinated strategy that balances immediate operational needs with sustained innovation investments. First, prioritize supply chain diversification and nearshoring options to reduce exposure to tariff-driven cost swings and lead-time variability, while simultaneously qualifying alternate material sources to preserve device performance characteristics. Second, design product portfolios that cover the full procedural spectrum by offering complementary geometries-such as clutch cutters and hook knives-and both disposable and reusable models to meet divergent end-user preferences. Third, invest in clinical evidence generation and structured training programs; compelling outcomes data paired with hands-on proctoring can accelerate adoption in hospitals and specialty clinics and facilitate inclusion in clinical guidelines.

Additionally, engage payers and procurement stakeholders early to demonstrate procedural value and align contracting approaches with institutional budget cycles. Operationally, develop validated sterilization protocols for reusable instruments and consider modular packaging innovations to streamline single-use logistics. From a commercial perspective, build distribution partnerships that offer bundled solutions-device supply, training, and data capture-to reduce friction at the point of adoption. Finally, monitor regulatory and tariff developments closely and use scenario planning to stress-test inventory and pricing strategies. These steps will help manufacturers and health systems deliver consistent clinical outcomes while navigating economic and geopolitical uncertainty.

Transparent research methodology combining clinician interviews, regulatory and patent analysis, supply chain mapping, and scenario testing to validate findings

The research underpinning this report synthesizes primary and secondary evidence to create a robust, actionable view of the endoscopic submucosal dissection knife landscape. Primary inputs included structured interviews with interventional endoscopists, procurement leaders, sterilization engineers, and clinical educators, plus observational insights from procedural sites and training centers. These qualitative inputs were triangulated with a review of regulatory filings, device instructions for use, clinical trial reports, and peer-reviewed literature to validate performance claims and safety profiles. Patent landscaping and materials analysis provided insight into technological differentiation and the competitive innovation pipeline.

Supply chain and tariff impact analysis combined customs data trends, supplier mapping exercises, and manufacturer disclosures to assess sourcing risk and mitigation strategies. Scenario analyses were conducted to evaluate the operational effects of shifts in manufacturing location, tariff imposition, and demand concentration across procedural settings. Throughout, data integrity checks and cross-validation procedures were implemented to ensure consistent interpretation of qualitative and documentary evidence. The methodology emphasizes transparency and reproducibility, leveraging expert validation and iterative review cycles to align findings with clinical practice realities and procurement constraints.

Concluding synthesis emphasizing the interplay between device innovation, supply resilience, clinical evidence, and regional adoption dynamics to guide strategic action

In conclusion, endoscopic submucosal dissection knives are at an inflection point driven by concurrent advances in device geometry, material science, and procedural training, while macroeconomic and policy forces such as tariffs are reshaping supply chain strategy. Clinical demand is broadening as more centers adopt advanced resection techniques, yet successful commercialization depends on aligning device attributes with the nuanced needs of different end users, clinical applications, and regional regulatory environments. Materials and mode choices-whether ceramic versus advanced steels or disposable versus reusable formats-remain pivotal decisions that affect sterilization workflows, clinician preference, and procurement economics.

Going forward, agility in manufacturing and distribution, coupled with strong clinical evidence and structured training initiatives, will determine which technologies achieve widespread adoption. Organizations that proactively address supply resilience, invest in outcomes research, and create practical adoption pathways for clinicians will be best positioned to capture the clinical and commercial benefits of these advanced dissection tools. The net result for patients and providers will be safer, more effective resections and improved procedural confidence across diverse clinical settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscopic Submucosal Dissection Knives Market, by Product Type

  • 8.1. Clutch Cutter
  • 8.2. Dual Knife
  • 8.3. Hook Knife
  • 8.4. Insulated Tip Knife

9. Endoscopic Submucosal Dissection Knives Market, by Mode

  • 9.1. Disposable
  • 9.2. Reusable

10. Endoscopic Submucosal Dissection Knives Market, by Material

  • 10.1. Ceramic
  • 10.2. High Carb Steel
  • 10.3. Stainless Steel

11. Endoscopic Submucosal Dissection Knives Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Endoscopic Submucosal Dissection Knives Market, by Application

  • 12.1. Colonic Lesions
  • 12.2. Duodenal Lesions
  • 12.3. Esophageal Lesions
  • 12.4. Gastric Lesions

13. Endoscopic Submucosal Dissection Knives Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endoscopic Submucosal Dissection Knives Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endoscopic Submucosal Dissection Knives Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endoscopic Submucosal Dissection Knives Market

17. China Endoscopic Submucosal Dissection Knives Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Boston Scientific Corporation
  • 18.6. CONMED Corporation
  • 18.7. Cook Medical LLC
  • 18.8. Creo Medical
  • 18.9. ENDO-FLEX GmbH
  • 18.10. Erbe Elektromedizin GmbH
  • 18.11. Finemedix
  • 18.12. FUJIFILM Holdings Corporation
  • 18.13. Hangzhou AGS
  • 18.14. Hoya Corporation
  • 18.15. Kachu
  • 18.16. KARL STORZ SE & Co. KG
  • 18.17. Medi-Globe GmbH
  • 18.18. Medtronic plc
  • 18.19. Micro-Tech Endoscopy Co., Ltd.
  • 18.20. MTW Endoskopie Manufaktur
  • 18.21. Olympus Corporation
  • 18.22. Ovesco Endoscopy AG
  • 18.23. STERIS plc
  • 18.24. Sumitomo Bakelite Co., Ltd.
  • 18.25. Taewoong Medical Co., Ltd.
  • 18.26. ZEON CORPORATION
  • 18.27. Zhejiang Soudon Medical Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY CLUTCH CUTTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY CLUTCH CUTTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY CLUTCH CUTTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DUAL KNIFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DUAL KNIFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DUAL KNIFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HOOK KNIFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HOOK KNIFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HOOK KNIFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY INSULATED TIP KNIFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY INSULATED TIP KNIFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY INSULATED TIP KNIFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY CERAMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY CERAMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY CERAMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HIGH CARB STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HIGH CARB STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HIGH CARB STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COLONIC LESIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COLONIC LESIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COLONIC LESIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DUODENAL LESIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DUODENAL LESIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DUODENAL LESIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY ESOPHAGEAL LESIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY ESOPHAGEAL LESIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY ESOPHAGEAL LESIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY GASTRIC LESIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY GASTRIC LESIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY GASTRIC LESIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 114. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 115. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 132. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 138. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)